Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities - Concepedia

Concepedia

Publication | Closed Access

Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities

117

Citations

30

References

2019

Year

Majid Mufaqam Syed‐Abdul, Elizabeth J. Parks, Ayman H. Gaballah, Kimberlee Bingham, Ghassan M. Hammoud, George Kemble, Douglas Buckley, William McCulloch, Camila Manrique‐Acevedo

Abstract

These data support the therapeutic potential of a fatty acid synthase inhibitor, TVB-2640 in particular, in patients with NAFLD and nonalcoholic steatohepatitis.

References

	Year	Citations

Page 1